Abide Therapeutics Report issue

For profit Phase 2
Founded: Princeton NJ United States (2011)
Status: Acquired by Lundbeck (2019)

Organization Overview

First Clinical Trial
2016
NCT02875678
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Abide Therapeutics | Abide Therapeutics, Inc.